Related Experiment Video
Updated: Sep 28, 2026

The Synergistic Effect of Visible Light and Gentamycin on Pseudomona aeruginosa Microorganisms
Published on: July 2, 2013
Bactericidal effect of gentamicin-induced membrane vesicles derived from Pseudomonas aeruginosa PAO1 on gram-positive
Kelly L MacDonald1, Terry J Beveridge
1Canadian Bacterial Diseases Network, National Centre of Excellence and Department of Microbiology, College of Biological Sciences, University of Guelph, Guelph, ON N1G 2W1, Canada.
Abstract:
Previous studies have shown that gentamicin-induced membrane vesicles (g-MVs) from Pseudomonas aeruginosa PAO1 possess both the antibiotic (gentamicin) and a potent peptidoglycan hydrolase (PGase; autolysin) that is effective in killing gram-negative pathogens. This present study evaluated the therapeutic potential of g-MVs against four gram-positive bacteria. Bactericidal assays and electron microscopy of thin sections revealed that Bacillus subtilis 168 and Staphylococcus aureus D2C were susceptible to killing mediated by g-MVs, Listeria monocytogenes ATCC 19113 was slightly susceptible, whereas Enterococcus hirae ATCC 9790 was unaffected. g-MVs were generally more effective against the bacteria than was soluble gentamicin, suggesting they could have more killing power than natural membrane vesicles containing no antibiotic. Electron microscopy and hydrophobic interaction chromatography showed that more membrane vesicles (MVs) initially attached to B. subtilis (hydrophilic) than to predominantly hydrophobic E. hirae, L. monocytogenes, and S. aureus. Zymograms containing murein sacculi as an enzyme substrate illustrated that all organisms except E. hirae were sensitive to the 26-kDa autolysin to varying degrees. Peptidoglycan O-acetylation did not influence susceptibility to MV-mediated lysis. Though not universally effective, the g-MV delivery system remains a promising therapeutic alternative for specific gram-positive infections.
Insights
Gentamicin-induced membrane vesicles (g-MVs) show therapeutic potential against some gram-positive bacteria by utilizing both gentamicin and autolysin. These g-MVs demonstrate enhanced efficacy compared to soluble gentamicin for specific bacterial infections.
Area of Science:
- Microbiology
- Bacteriology
- Drug Delivery Systems
Background:
- Pseudomonas aeruginosa PAO1 produces gentamicin-induced membrane vesicles (g-MVs).
- g-MVs contain both the antibiotic gentamicin and a potent peptidoglycan hydrolase (PGase; autolysin).
- g-MVs have previously shown efficacy against gram-negative pathogens.
Purpose of the Study:
- To evaluate the therapeutic potential of g-MVs against four gram-positive bacteria.
- To compare the efficacy of g-MVs with soluble gentamicin.
- To investigate the mechanism of g-MV interaction with gram-positive bacterial cell surfaces.
Main Methods:
- Bactericidal assays were performed against Bacillus subtilis, Staphylococcus aureus, Listeria monocytogenes, and Enterococcus hirae.
- Electron microscopy was used to examine thin sections of bacteria treated with g-MVs.
- Hydrophobic interaction chromatography and zymograms were employed to analyze MV attachment and autolysin activity.
Main Results:
- Bacillus subtilis and Staphylococcus aureus were susceptible to g-MV killing, while Listeria monocytogenes showed slight susceptibility, and Enterococcus hirae was unaffected.
- g-MVs were generally more effective than soluble gentamicin.
- MV attachment varied based on bacterial surface hydrophobicity, and autolysin activity was observed in most tested organisms except E. hirae.
Conclusions:
- g-MVs exhibit selective bactericidal activity against certain gram-positive bacteria.
- The dual action of gentamicin and autolysin contributes to g-MV efficacy.
- g-MVs represent a promising therapeutic strategy for specific gram-positive bacterial infections, warranting further investigation.
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Inhibitors of Bacterial Protein Synthesis
Mechanism of Antibiotic Resistance in MRSA
Gene Regulation in Microbial Communities: Quorum Sensing
Clinical Significance of Antibiotic Resistance
Bacterial Cell Wall

